Novel approach designed to address dysregulated RNA splicing events that drive tumor growth and disease progression across ...

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced an ...

BOSTON and LONDON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

NEW ORLEANS, LA – Ten Indian American scientists were honored for their outstanding contributions in cancer research by the Society of American Asian Scientists in Cancer Research (SAASCR) on April 10 ...

Mutations in ZRSR2 have been linked with disease progression in patients with JAK2 V617R – driven myeloproliferative neoplasms (MPNs), but a new report suggests that loss of ZRSR2 alone is not ...